We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Carbon Fiber Implants Beneficial for Oncological Patients

By HospiMedica International staff writers
Posted on 15 Oct 2018
A novel carbon fiber pedicle screw system restores the integrity of the spinal column in patients with advanced-stage cancer in whom life expectancy is too short to permit fusion.

The CarboFix Orthopedics (CarboFix; Herzliya, Israel) CarboClear Pedicle Screw System is intended to restore the integrity of the thoracic and lumbar spine--even in the absence of fusion--for a limited period in patients with advanced tumors. More...
The implant system consists of pedicle screws, rods, intramedullary nails, plates, and locking elements in various dimensions, used to build a spinal construct; and of a set of instruments, intended to assist in the insertion and placement of the implants. The threaded portion of the pedicle screws is encased within a thin titanium shell.

The system elements are made of carbon fiber-reinforced polyetheretherketone (CFR-PEEK), consisting of continuous carbon fibers layered in a unidirectional, longitudinal orientation, as well as in a helical and diagonal orientation, which adhere together. The composite material makes the CarboFix implants radiolucent, which is beneficial during surgery and follow up on magnetic resonance imaging (MRI) and computerized tomography (CT) scans with minimal artifacts. The material also enables radiation therapy (RT) with no backscatters.

“These unique implants provide enhanced imaging follow-up and radiation treatment. These implants are a game changer for spinal oncology cases,” said Ron Szekely, director of VP sales and marketing at CarboFix. “This is another major breakthrough for CarboFix in its endeavor to bring the next revolution, using carbon fibers as the material of choice in orthopedic implants. We will continue to broaden our portfolio for the spine as we did with our full range trauma line.”

Carbon fiber implants provide unique advantages to the oncological patients, including enhanced RT planning capabilities, allowing dose optimization with minimal collateral tissue damage and enhanced follow up abilities due to artifacts-free MRI and CT. In addition, unparalleled fatigue strength supports the impaired healing process in such patients, as well as compatibility with particle radiation (proton and carbon ion) and other stereotactic radio-surgery modalities.

Related Links:
CarboFix Orthopedics


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.